Biomechanical stiffening: Slow low-irradiance corneal crosslinking versus the standard Dresden protocol

J Cataract Refract Surg. 2017 Jul;43(7):975-979. doi: 10.1016/j.jcrs.2017.04.041.

Abstract

Purpose: To assess whether full biomechanical stiffening can be achieved with corneal crosslinking (CXL) when applying a reduced ultraviolet (UV) fluence during the standard irradiation time.

Setting: Laboratory of Ocular Cell Biology, Center for Applied Biotechnology and Molecular Medicine, University of Zurich, Zurich, Switzerland.

Design: Experimental study.

Methods: Thirty-four freshly enucleated porcine corneas were deepithelialized and soaked with hypoosmolar riboflavin 0.1% solution for 30 minutes. Slow low-irradiance CXL (30 minutes at 1.5 mW/cm2, fluence 2.7 J/cm2) was compared with standard CXL (30 minutes at 3 mW/cm2, fluence 5.4 J/cm2). The controls were soaked with riboflavin but not exposed to UV light. Elastic (stress-strain) and viscoelastic (stress-relaxation) 2-dimensional testing was performed with a commercial stress-strain extensometer to quantify the biomechanical stiffening.

Results: Corneas crosslinked with low and standard UV irradiances had a significantly higher mean elastic modulus (65.9 MPa ± 15.7 [SD] and 67.1 ± 15.6 MPa, respectively) than controls (52.4 ± 12.3 MPa) (P < .001). Also, the remaining stress after 120 seconds of stress-relaxation was significantly higher after CXL with low and standard UV irradiances (159 ± 21 kPa and 158 ± 25 kPa, respectively) compared with controls (135 ± 20 kPa) (P ≤ .013). No difference was observed in low and standard irradiances between CXL conditions (P = .64).

Conclusions: The UV fluence for CXL might be reduced while maintaining the biomechanical efficacy by using a lower UV irradiance and the same irradiation duration. This might open avenues in the treatment of extremely thin corneas.

MeSH terms

  • Animals
  • Biomechanical Phenomena
  • Cornea*
  • Corneal Stroma* / drug effects
  • Cross-Linking Reagents* / pharmacology
  • Elastic Modulus
  • Riboflavin* / pharmacology
  • Swine
  • Ultraviolet Rays*

Substances

  • Cross-Linking Reagents
  • Riboflavin